Navan, Inc.

Company NAVN

Last mentioned: Mar 5, 2026

Timeline

  1. Lead Plaintiff Deadline

    Estimated deadline for investors to file motions to be appointed as lead plaintiff in the respective cases.

  2. Market Reaction

    Investors and analysts begin assessing the potential litigation overhang on RARE, MREO, FRMI, and NAVN.

  3. Investor Alerts Issued

    Pomerantz Law Firm releases simultaneous reminders for class action lawsuits against four companies.

Stories mentioning Navan, Inc. 1

Corporate Law Neutral

Pomerantz Law Firm Targets Biotech and Tech Sectors in Securities Class Actions

Pomerantz Law Firm has issued a series of investor alerts regarding class action lawsuits against Ultragenyx Pharmaceutical, Fermi Inc., Mereo BioPharma, and Navan, Inc. These filings highlight a surge in securities litigation targeting volatility in the biotechnology and emerging technology sectors, emphasizing critical lead plaintiff deadlines for affected shareholders.

4 sources